MULTIPLE-DRUG EFFECT ANALYSIS WITH CONFIDENCE-INTERVAL

被引:63
作者
BELENKII, MS
SCHINAZI, RF
机构
[1] VET AFFAIRS MED CTR,DECATUR,GA 30033
[2] EMORY UNIV,SCH MED,BIOCHEM PHARMACOL LAB,ATLANTA,GA 30322
关键词
DRUG INTERACTION; MONTE CARLO SIMULATION; COMBINATION INDEX; CONFIDENCE INTERVAL;
D O I
10.1016/0166-3542(94)90089-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The development of mathematical models for determining antagonism, synergy or additivism for drug combinations is becoming increasingly important in medical research and medicine. This paper describes improvements in the Chou and Talalay method which provides for the first time confidence intervals for the combination index. The Monte Carlo technique was used to calculate the confidence intervals and to obtain the new parameters which are needed for the modified interaction diagnosis. This new method can be adapted to current as well as future formulae used to evaluate drug combinations. Programs written in Microsoft and Visual Basic were developed for use on commonly available personal computers which we call Combostat(R).
引用
收藏
页码:1 / 11
页数:11
相关论文
共 21 条
  • [1] ISOBOLOGRAPHIC, ALGEBRAIC, AND SEARCH METHODS IN THE ANALYSIS OF MULTIAGENT SYNERGY
    BERENBAUM, MC
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF TOXICOLOGY, 1988, 7 (07): : 927 - 938
  • [2] Bratley P, 1983, GUIDE SIMULATION
  • [3] BUSLENKO NP, 1966, MONTE CARLO METHOD M
  • [4] Chou T, 1991, SYNERGISM ANTAGONISM, V1, P61
  • [5] QUANTITATIVE-ANALYSIS OF DOSE-EFFECT RELATIONSHIPS - THE COMBINED EFFECTS OF MULTIPLE-DRUGS OR ENZYME-INHIBITORS
    CHOU, TC
    TALALAY, P
    [J]. ADVANCES IN ENZYME REGULATION, 1984, 22 : 27 - 55
  • [6] Eriksson BF, 1989, ANTIMICROB AGENTS CH, V33, P778
  • [7] GRECO WR, 1990, CANCER RES, V50, P5318
  • [8] 2-DRUG COMBINATIONS OF ZIDOVUDINE, DIDANOSINE, AND RECOMBINANT INTERFERON-ALPHA A INHIBIT REPLICATION OF ZIDOVUDINE-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SYNERGISTICALLY INVITRO
    JOHNSON, VA
    MERRILL, DP
    VIDELER, JA
    CHOU, TC
    BYINGTON, RE
    ERON, JJ
    DAQUILA, RT
    HIRSCH, MS
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (04) : 646 - 655
  • [9] INVITRO INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE-1 REPLICATION BY C2 SYMMETRY-BASED HIV PROTEASE INHIBITORS AS SINGLE AGENTS OR IN COMBINATIONS
    KAGEYAMA, S
    WEINSTEIN, JN
    SHIRASAKA, T
    KEMPF, DJ
    NORBECK, DW
    PLATTNER, JJ
    ERICKSON, J
    MITSUYA, H
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (05) : 926 - 933
  • [10] COMPARISONS OF ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS ACTIVITIES, CELLULAR-TRANSPORT, AND PLASMA AND INTRACELLULAR PHARMACOKINETICS OF 3'-FLUORO-3'-DEOXYTHYMIDINE AND 3'-AZIDO-3'-DEOXYTHYMIDINE
    KONG, XB
    ZHU, QY
    VIDAL, PM
    WATANABE, KA
    POLSKY, B
    ARMSTRONG, D
    OSTRANDER, M
    LANG, SA
    MUCHMORE, E
    CHOU, TC
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (04) : 808 - 818